2007
DOI: 10.1345/aph.1h577
|View full text |Cite
|
Sign up to set email alerts
|

Book Review: Hematology–Oncology Therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
53
0

Year Published

2008
2008
2016
2016

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 19 publications
(53 citation statements)
references
References 0 publications
0
53
0
Order By: Relevance
“…26 Only 7 texts cite either guideline in their lists of references. 10,11,[13][14][15]23,27 Nonetheless, treatment recommendations are consistent with these guidelines in only 2 of them. 10,15 Comparison with opioid use in other acute pain settings VOC is often treated by physicians with little experience in acute pain management in other settings.…”
Section: Textbook Recommendations For Opioid Use For Vocs In Scdmentioning
confidence: 99%
See 1 more Smart Citation
“…26 Only 7 texts cite either guideline in their lists of references. 10,11,[13][14][15]23,27 Nonetheless, treatment recommendations are consistent with these guidelines in only 2 of them. 10,15 Comparison with opioid use in other acute pain settings VOC is often treated by physicians with little experience in acute pain management in other settings.…”
Section: Textbook Recommendations For Opioid Use For Vocs In Scdmentioning
confidence: 99%
“…[6][7][8] These observations prompted a review of 19 textbooks in hematology, internal medicine, and emergency medicine published during or after the year 2003 to identify barriers to the effective management of VOCs in SCD. [9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27] (Specific chapters reviewed in each textbook are listed in Document S1, available on the Blood website; see the Supplemental Materials link at the top of the online article).…”
Section: Introductionmentioning
confidence: 99%
“…The most common side effects are nausea and/or vomiting. Aggressive and proactive management of these symptoms with antiemetic medications is extremely important to mitigate these effects, Another very frequent problem with the FOLFIRI chemotherapy is diarrhea which, like the nausea, requires active management by one's oncology team 6,7 . It has rarely been involved in hypersensitivity reactions as flushing, pruritus, abdominal pain,erythema, oedema developed over the face and thorax 8 .…”
Section: Discussionmentioning
confidence: 99%
“…Paclitaxel -no adjustment required. 33,34 B. Liver Function 1. Carboplatin -no dose adjustment required.…”
Section: Dosage Modifications a Renal Functionmentioning
confidence: 99%
“…Carboplatin -no dose adjustment required. 33 2. Paclitaxel -bilirubin and ALT/AST: a. Bilirubin less than 1.5 mg/dL and/or ALT/ AST greater than 2 times the ULN, reduce the dose 25%.…”
Section: Dosage Modifications a Renal Functionmentioning
confidence: 99%